Ricardo G. Teixeira

Lisbon, 1749016, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Lysosome-targeted Ru(II)-cyclopentadienyl organometallic anticancer complexes.

Lysosome-targeted Ru(II)-cyclopentadienyl organometallic anticancer complexes.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: November 06, 2025

An AI-Based Solution for Denoising Fast-Acquisition [18F]FDG PET: Clinical Feasibility and Quantitative Assessment.

An AI-Based Solution for Denoising Fast-Acquisition [18F]FDG PET: Clinical Feasibility and Quantitative Assessment.

Journal: Journal of imaging informatics in medicine

Published: February 17, 2025

A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound.

A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound.

Journal: Pharmacological research

Published: April 01, 2024

Author Correction: Contactless doping characterization of Ga2O3 using acceptor Cd probes.

Author Correction: Contactless doping characterization of Ga2O3 using acceptor Cd probes.

Journal: Scientific reports

Published: March 21, 2024

Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands.

Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands.

Journal: Journal of medicinal chemistry

Published: February 24, 2024

Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies.

Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies.

Journal: European journal of medicinal chemistry

Published: September 29, 2023

Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling.

Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling.

Journal: Journal of inorganic biochemistry

Published: September 19, 2023

Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.

Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.

Journal: Journal of medicinal chemistry

Published: August 24, 2023

The current role of nuclear medicine in breast cancer.

The current role of nuclear medicine in breast cancer.

Journal: The British journal of radiology

Published: April 25, 2023

Evaluation of Semiautomatic and Deep Learning-Based Fully Automatic Segmentation Methods on [18F]FDG PET/CT Images from Patients with Lymphoma: Influence on Tumor Characterization.

Evaluation of Semiautomatic and Deep Learning-Based Fully Automatic Segmentation Methods on [18F]FDG PET/CT Images from Patients with Lymphoma: Influence on Tumor Characterization.

Journal: Journal of digital imaging

Published: January 03, 2023

Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation.

Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation.

Journal: Journal of inorganic biochemistry

Published: September 25, 2022

Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.

Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.

Journal: Pharmaceutics

Published: May 18, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026